Annual Drug Patent Expirations for AVANDAMET
Avandamet is a drug marketed by Sb Pharmco and is included in one NDA. There is one patent protecting this drug and one Paragraph IV challenge.
Drug patent litigation for AVANDAMET.
This drug has sixty-five patent family members in forty-four countries.
The generic ingredient in AVANDAMET is metformin hydrochloride; rosiglitazone maleate. Additional details are available on the metformin hydrochloride; rosiglitazone maleate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com